摘要
目的探讨野生云芝多糖水溶性新组分CVPS-B对RAW264.7巨噬细胞膜硫酸软骨素-蛋白聚糖(CS-PGs)结合氧化修饰低密度脂蛋白(Ox-LDL)的影响。方法分别用溴化氰活化的Sepharose CL-4B亲和层析及体外结合CS-A的方法分别测定CS/PGs与Ox-LDL的结合率;用离子交换层析提取RAW264.7巨噬细胞膜PGs;用1,9-二甲基亚甲基蓝(DMMB)分光光度法测定糖胺聚糖。结果在17μmol MDA·g-1protein Ox-LDL水平,不同剂量CVPS-B(10、50及100μg)在体外降低Ox-LDL(200μg)与CS-A(100μg)结合,分别降低14%、29%(P<0.05)及43%(P<0.01)。不同剂量CVPS-B(10、50及100μg)在体外降低Ox-LDL(17μmol MDA·g-1 protein)与巨噬细胞膜表面PGs结合,分别降低8%、27%(P<0.05)及38%(P<0.01)。不同剂量CVPS-B可抑制Ox-LDL(50mg·L-1,17μmol MDA·g-1 protein)诱导泡沫细胞的形成。结论CVPS-B可体外抑制巨噬细胞膜CS-PGs结合Ox-LDL。
Aim To identify the effects of CVPS-B on RAW264.7 macrophage plasma membrane chondroitin sulfate ( CS ) -proteoglycans ( PGs ) binging oxidized low-density lipoprotein (Ox-LDL). Methods Rates of PGs binding Ox-LDL were analyzed by their abilities to bind Ox-LDL coupled to a CnBr-activated Sepharose CL-4B chromatography, and rates of CS-A binding Ox- LDL were determined in vitro membrane PGs were isolated RAW264. 7 macrophages by anion exchange chromatography. Glycosaminoglycans were analyzed through the DMMB spectrophoto-metric assay. Results At the level of LDL oxidation (17 μmol MDA·g^-1 Pro), however, CVPS-B (10, 50, 100 μg) in vitro decreased the ability of CS-A ( 100 μg ) binding Ox-LDL (200μg) by 14%, 29% (P〈0.05), and43% (P〈0.01 ), respectively. Furthermore, the binding of the PGs to Ox-LDL ( 17 μmol MDA·g-1 Pro) was decreased by 8%, 27% (P〈0.05), and 38% (P〈0.01) , respectively after CVPS-B ( 10, 50, and 100 μg) being pre-incubated. CVPS-B could inhibit Ox- LDL (50 mg·L^-1 ,17 μmol MDA·g^-1 Pro)-indueed foam cell formation. Conclusions These data provide the first evidence that CVPS-B can inhibit the macrophage surface CS-PGs binding Ox-LDL in vitro.
出处
《中国药理学通报》
CAS
CSCD
北大核心
2009年第9期1181-1184,共4页
Chinese Pharmacological Bulletin
基金
国家自然科学基金资助项目(No39700177)
关键词
云芝多糖
蛋白聚糖
硫酸软骨素
低密度脂蛋白
巨噬细胞
动脉粥样硬化
炎症
coriolus versicolor
proteoglyeans
chondroitin sulfate
low-density lipoprotein
maerophages
atherosclerosis
inflammation